Guanidinoacetate methyltransferase deficiency: differences of creatine uptake in human brain and muscle

Molecular Genetics and Metabolism
R EnsenauerW Lehnert

Abstract

Deficiency of guanidinoacetate methyltransferase (GAMT), the first described creatine biosynthesis defect, leads to depletion of creatine and phosphocreatine, and accumulation of guanidinoacetate in brain. This results in epilepsy, mental retardation, and extrapyramidal movement disorders. Investigation of skeletal muscle by proton and phosphorus magnetic resonance spectroscopy before therapy demonstrated the presence of considerable amounts of creatine and phosphocreatine, and accumulation of phosphorylated guanidinoacetate in a 7-year-old boy diagnosed with GAMT deficiency, suggesting separate mechanisms for creatine uptake and synthesis in brain and skeletal muscle. The combination of creatine supplementation and a guanidinoacetate-lowering therapeutic approach resulted in improvement of clinical symptoms and metabolite concentrations in brain, muscle, and body fluids.

References

Jan 1, 1987·Annals of the New York Academy of Sciences·P A Bottomley
Nov 21, 1997·Pediatric Neurology·V GanesanR A Surtees
Aug 1, 1998·European Journal of Pediatrics·A SchulzeD Rating
Feb 8, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·J IlasS Stöckler-Ipsiroglu
Feb 13, 2001·Brain Research. Molecular Brain Research·O BraissantC Bachmann
Jan 31, 2003·Annals of Neurology·Andreas SchulzeErtan Mayatepek
Mar 4, 2003·Journal of Applied Physiology·Jeffrey J BraultRonald L Terjung

❮ Previous
Next ❯

Citations

May 3, 2014·Journal of Inherited Metabolic Disease·Jiddeke M van de KampGajja S Salomons
Oct 3, 2007·Journal of the International Society of Sports Nutrition·Thomas W BufordJose Antonio
Jan 19, 2012·Journal of Inherited Metabolic Disease·Olivier Braissant
Mar 11, 2011·Amino Acids·Olivier BraissantJoséphine Uldry
Dec 14, 2012·Orphanet Journal of Rare Diseases·David CheillanJoseph Vamecq
Mar 18, 2009·Brain & Development·Neil Gordon
Apr 22, 2008·European Journal of Radiology·Monika Dezortova, Milan Hajek
Feb 11, 2011·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Nicola LongoMarzia Pasquali
Aug 28, 2010·Journal of Neurochemistry·Elidie Béard, Olivier Braissant
Sep 20, 2005·Molecular Genetics and Metabolism·P E SijensR J Soorani-Lunsing
Oct 25, 2011·Molecular Genetics and Metabolism·Saadet Mercimek-MahmutogluCornelis Jakobs
Sep 28, 2013·Molecular Genetics and Metabolism·Krista S ViauNicola Longo
May 11, 2013·Molecular Genetics and Metabolism·Matthew S ComeauxLee-Jun Wong
Apr 14, 2007·Annual Review of Nutrition·John T Brosnan, Margaret E Brosnan
Jan 6, 2017·Genetics in Medicine : Official Journal of the American College of Medical Genetics·J Daniel SharerSarah Young
Jun 16, 2017·Journal of the International Society of Sports Nutrition·Richard B KreiderHector L Lopez
Sep 3, 2011·Surgical Neurology International·Russell L Blaylock, Joseph Maroon
Oct 2, 2013·Surgical Neurology International·Russell L Blaylock
Jul 4, 2012·The Journal of Clinical Investigation·Yuko KurosawaJoseph F Clark
Feb 8, 2008·Neurochemical Research·Roselia Maria SpanevelloMaria Rosa Chitolina Schetinger
Nov 20, 2012·Epilepsia·Vincenzo LeuzziGiovanni Cioni
Feb 13, 2021·Nutrients·Richard B Kreider, Jeffery R Stout

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.